Exchange: NASDAQ·Updated 07:54 AM EDT
INSM logo

INSM Insmed Inc

$126.82
$0.14
(0.11%)
Pre-Market
Prev Close $126.68
Reported EarningsAug 6
Mkt Cap$27.66B
Vol199.00

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
35

Bearish Sentiment

How do you feel about INSM?

Advertisement|Remove ads.